Bioventus Reports Second Quarter Financial Results

Q2 reported revenue of $153.2 million increased 4% Q2 GAAP earnings of $0.47 per diluted share compared to the prior-year period earnings of $0.11 per diluted share Non-GAAP earnings* of $0.22 per diluted share compared to $0.21 per diluted share in the prior-year period Cash from operations